Matches in Wikidata for { <http://www.wikidata.org/entity/Q80262561> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q80262561 description "2007 թվականի հոկտեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q80262561 description "article scientifique publié en 2007" @default.
- Q80262561 description "artículu científicu espublizáu n'ochobre de 2007" @default.
- Q80262561 description "im Oktober 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80262561 description "scientific article published on 10 October 2007" @default.
- Q80262561 description "wetenschappelijk artikel" @default.
- Q80262561 description "наукова стаття, опублікована в жовтні 2007" @default.
- Q80262561 name "Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study" @default.
- Q80262561 name "Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study" @default.
- Q80262561 type Item @default.
- Q80262561 label "Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study" @default.
- Q80262561 label "Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study" @default.
- Q80262561 prefLabel "Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study" @default.
- Q80262561 prefLabel "Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study" @default.
- Q80262561 P1433 Q80262561-71B6E642-1FF3-4399-A9F3-6D5106743936 @default.
- Q80262561 P1476 Q80262561-0E125EC0-CFD2-46DE-889F-8BDB9DFDC0E3 @default.
- Q80262561 P2093 Q80262561-839E8EFA-6A42-483A-B699-C1DFCBFC5135 @default.
- Q80262561 P304 Q80262561-9CA8F551-A735-4593-B9C5-068D7A693F00 @default.
- Q80262561 P31 Q80262561-4ac491f2-8a0e-475f-a0ef-2dc86077dedb @default.
- Q80262561 P31 Q80262561-8B3713BB-2778-475E-AB78-9D973329DB4A @default.
- Q80262561 P356 Q80262561-49126736-49DF-4196-8508-F028480F5DD1 @default.
- Q80262561 P433 Q80262561-53040BB7-8B65-4B89-A424-7F3502A27A1B @default.
- Q80262561 P478 Q80262561-C26224F7-0496-4C8E-AFE0-B36E6872CA2D @default.
- Q80262561 P577 Q80262561-F0727335-572C-4B7A-B17D-40AE86FCD2D9 @default.
- Q80262561 P698 Q80262561-E0F49D11-0CE4-4CA2-9D23-34A3C0BBE58E @default.
- Q80262561 P921 Q80262561-AB6DC327-AA6D-4641-8CA6-FB1CF8D690C9 @default.
- Q80262561 P921 Q80262561-C376AE9B-B80C-4364-91C0-6B1A5123ED67 @default.
- Q80262561 P356 J.EURURO.2007.04.044 @default.
- Q80262561 P698 17478035 @default.
- Q80262561 P1433 Q15763991 @default.
- Q80262561 P1476 "Editorial comment on: Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study" @default.
- Q80262561 P2093 "Andrea Salonia" @default.
- Q80262561 P304 "1775-1776" @default.
- Q80262561 P31 Q13442814 @default.
- Q80262561 P31 Q871232 @default.
- Q80262561 P356 "10.1016/J.EURURO.2007.04.044" @default.
- Q80262561 P433 "6" @default.
- Q80262561 P478 "52" @default.
- Q80262561 P577 "2007-10-10T00:00:00Z" @default.
- Q80262561 P698 "17478035" @default.
- Q80262561 P921 Q184674 @default.
- Q80262561 P921 Q269829 @default.